Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06447597
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-06-03
Brief Title:
A Clinical Study to Evaluate Safety Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers
Sponsor:
Shanghai Jiaolian Drug Research and Development Co Ltd
Organization:
Shanghai Jiaolian Drug Research and Development Co Ltd
Study Overview
Official Title:
A Randomized Double-blind Placebo-controlled Multicenter Phase IIIII Clinical Study to Evaluate the Efficacy and Safety of B007 in Subjects With Generalized Myasthenia Gravis
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with generalized myasthenia gravis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None